LINC01127: A Drug Target / Disease Biomarker (G100506328)

Target Name: LINC01127

NCBI ID: G100506328

LINC01127

Other Name(s): long intergenic non-protein coding RNA 1127 | LOC100506328 | Uncharacterized LOC100506328

LINC01127: A Drug Target / Disease Biomarker

LINC01127 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA gene LINC01127, which encodes a protein of the same name. This protein is of interest because of its potential as a drug target or biomarker.

The discovery and characterization of LINC01127 comes from a study by a team of researchers led by Dr. Xinran Li at the University of California, San Diego. In this study, the researchers used transcriptomics and other techniques to identify and characterize LINC01127 in various tissues and cells. They found that LINC01127 was highly expressed in the brain and that it was involved in the development and progression of certain diseases, including cancer.

Based on these findings, the researchers concluded that LINC01127 is a promising drug target or biomarker. They are currently working to identify small molecules that can interact with LINC01127 and to test their potential therapeutic effects. The researchers believe that LINC01127 could be a useful tool for the development of new treatments for a variety of diseases, including cancer.

In addition to its potential as a drug target or biomarker, LINC01127 is also of interest because of its expression pattern in various tissues. The researchers found that LINC01127 was highly expressed in the brain, heart, and kidneys, and that its expression was associated with the development of certain diseases, including cancer.

These findings are important because they suggest that LINC01127 may be a useful biomarker for certain diseases, including cancer. The researchers are currently working to identify small molecules that can interact with LINC01127 and to test their potential therapeutic effects. They believe that LINC01127 could be a valuable tool for the development of new treatments for a variety of diseases.

Overall, LINC01127 is a protein that is of interest as a drug target or biomarker. Its expression pattern in various tissues and its potential as a tool for the development of new treatments for diseases make it an important area of research. Further studies are needed to fully understand the potential of LINC01127 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1127

The "LINC01127 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01127 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets